Chronic Obstructive Pulmonary Diseases-Journal of the Copd Foundation

Papers
(The TQCC of Chronic Obstructive Pulmonary Diseases-Journal of the Copd Foundation is 1. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2020-03-01 to 2024-03-01.)
ArticleCitations
Objectively Measured Physical Activity in Patients with COPD: Recommendations from an International Task Force on Physical Activity14
Impact of Chronic Obstructive Pulmonary Disease and Emphysema on Outcomes of Hospitalized Patients with Coronavirus Disease 2019 Pneumonia10
Impact of Proactive Integrated Care on Chronic Obstructive Pulmonary Disease7
The Heterogeneity of COPD Patients in a Community-Based Practice and the Inadequacy of the Global Initiative for Chronic Obstructive Lung Disease Criteria: A Real-World Experience7
Randomization to Omega-3 Fatty Acid Supplementation and Endothelial Function in COPD: The COD-Fish Randomized Controlled Trial7
Protocol Summary of the COPD Assessment in Primary Care To Identify Undiagnosed Respiratory Disease and Exacerbation Risk (CAPTURE) Validation in Primary Care Study6
Progression of Emphysema and Small Airways Disease in Cigarette Smokers5
Exploring the Patient Experience with Noninvasive Ventilation: A Human-Centered Design Analysis to Inform Planning for Better Tolerance4
Home Non-Invasive Ventilation in COPD: A Global Systematic Review4
Trends and Characteristics of Global Initiative for Chronic Obstructive Lung Disease Guidelines-Discordant Prescribing of Triple Therapy Among Patients with COPD4
Outcomes of Patients with COPD Hospitalized for Coronavirus Disease 20193
Improving Screening for Alpha-1 Antitrypsin Deficiency with Direct Testing in the Pulmonary Function Testing Laboratory3
Higher COPD Assessment Test Score Associated With Greater Exacerbations Risk: A Post Hoc Analysis of the IMPACT Trial3
Forced Expiratory Flow at 25%-75% Links COPD Physiology to Emphysema and Disease Severity in the SPIROMICS Cohort3
Giving Voice to People – Experiences During Mild to Moderate Acute Exacerbations of COPD3
Decrease in Exacerbations During the Coronavirus Disease 2019 Pandemic in a Cohort of Veterans with COPD3
Cytomegalovirus Seropositivity is Associated with Airflow Limitation in a Cohort of Veterans with a High Prevalence of Smoking3
New Adopters of Telemedicine During the Coronavirus-19 Pandemic in Respondents to an Online Community Survey: The Case for Access to Remote Management Tools for Individuals with Chronic Obstructive Pu3
Comprehensive and Collaborative Pharmacist Transitions of Care Service for Underserved Patients with Chronic Obstructive Pulmonary Disease2
Adding Granularity of COPD Self-Management to Impact Quality of Life2
Does Evaluation and Management of COPD Follow Therapeutic Strategy Recommendations?2
Comparative Effectiveness of Roflumilast and Azithromycin for the Treatment of Chronic Obstructive Pulmonary Disease2
Varenicline for Gradual Versus Abrupt Smoking Cessation in Poorly Motivated Smokers With COPD: A Prematurely Terminated Randomized Controlled Trial2
Bronchoalveolar Lavage and Plasma Cathelicidin Response to 25-Hydroxy Vitamin D Supplementation: A Pilot Study2
Short-Term Impact of the Frequency of COPD Exacerbations on Quality of Life2
Comprehensive and Collaborative Pharmacist Transitions of Care Service for Underserved Patients with Chronic Obstructive Pulmonary Disease2
Effect of Two Interventional Strategies on Improving Continuous Positive Airway Pressure Adherence in Existing COPD and Obstructive Sleep Apnea Patients: The O2VERLAP Study2
Patterns and Predictors of Air Cleaner Adherence Among Adults with COPD2
Increased Health Care Resource Utilization and Costs Associated with Herpes Zoster Among Patients Aged ≥50 Years with Chronic Obstructive Pulmonary Disease in the United States2
Pilot Study of a Patient Experience with an ELLIPTA Inhaler Electronic Medication Monitor and Associated Integrated System: A Prospective Observational Study Using the COPD Patient-Powered Research Ne2
Chronic Obstructive Pulmonary Disease Outcomes at Veterans Affairs Versus Non-Veterans Affairs Hospitals2
Symptom Burden and Medication Use Among Patients with Nontuberculous Mycobacterial Lung Disease2
Impact of a Medical Diagnosis on Decision to Stop Smoking and Successful Smoking Cessation2
Home-based Pulmonary Rehabilitation is Effective in Frail COPD Patients with Chronic Respiratory Failure2
Pulmonary Rehabilitation and Readmission Rates for Medicare Beneficiaries with Acute Exacerbation of Chronic Obstructive Pulmonary Disease2
The Alchemy for a Behavior Change in COPD: The Combination of Personalized Care, the Proper Environment, Patient Motivation, and the Right Tools2
Antibody Response to Severe Acute Respiratory Syndrome Coronavirus-2 Vaccination in COPD: A Cohort Study1
Machine Learning Prediction of Progression in Forced Expiratory Volume in 1 Second in the COPDGene® Study1
Circulating Exosomes and Ambient Air Pollution Exposure in COPD1
Common Respiratory Pathogens Other Than Haemophilus in Small Airways Are Associated With Neutrophilic Inflammation and Poor Health Status in Stable COPD Patients1
Impact of Coronavirus Disease 2019-Related Infection Prevention and Control Measures on the Occurrence of COPD Exacerbations During Inpatient Pulmonary Rehabilitation1
Differences in Sedentary Time, Light Physical Activity, and Steps Associated with Better COPD Quality of Life1
Self-reported COPD Medication Use and Adherence in the COPD Foundation Patient- Powered Research Network1
Patient-Reported Pulmonary Symptoms, Exacerbations, and Management in a Cohort of Patients With Alpha-1 Antitrypsin Deficiency1
Mortality Risk and Serious Cardiopulmonary Events in Moderate-to-Severe COPD: Post Hoc Analysis of the IMPACT Trial1
A Conceptual Framework for Use of Increased Endurance Time During Constant Work Rate Cycle Ergometry as a Patient-Focused Meaningful Outcome in COPD Clinical Trials1
Outcomes Important to Patients Diagnosed with Both COPD and Sleep Apnea: Findings from the O2VERLAP Study Focus Groups1
Characterizing COPD Symptom Variability in the Stable State Utilizing the Evaluating Respiratory Symptoms in COPD Instrument1
Age-Dependent Associations Between 25-Hydroxy Vitamin D Levels and COPD Symptoms: Analysis of SPIROMICS1
InforMing the PAthway of COPD Treatment (IMPACT Trial) Single-Inhaler Triple Therapy (Fluticasone Furoate/Umeclidinium/Vilanterol) Versus Fluticasone Furoate/Vilanterol and Umeclidinium/Vilanterol in 1
Journal Club: The Intersection of Racial/Ethnic Disparities in Coronavirus Disease 2019 and COPD1
Predicting COPD Progression in Current and Former Smokers Using a Joint Model for Forced Expiratory Volume in 1 Second and Forced Expiratory Volume in 1 Second to Forced Vital Capacity Ratio1
Associations Between Muscle Weakness and Clinical Outcomes in Current and Former Smokers1
Elastin Degradation and Lung Function Deterioration with Remote Secondhand Tobacco Smoke Exposure in Never-smokers1
Urine and Plasma Markers of Platelet Activation and Respiratory Symptoms in COPD1
Differences of the Nasal Microbiome and Mycobiome by Clinical Characteristics of COPD Patients1
High Prevalence of Suboptimal Peak Inspiratory Flow in Hospitalized Patients With COPD: A Real-world Study1
Beyond Access: Factors Associated With Spirometry Underutilization Among Patients With a Diagnosis of COPD in Urban Tertiary Care Centers1
Exacerbations of Lung Disease in Alpha-1 Antitrypsin Deficiency1
Inhaled Corticosteroids and Risk of Cardiovascular Disease in Chronic Obstructive Pulmonary Disease: A Systematic Review and Meta-Regression1
Journal Club: Biologics and Potential for Immune Modulation in Chronic Obstructive Lung Disease1
Losartan Effects on Emphysema Progression Randomized Clinical Trial: Rationale, Design, Recruitment, and Retention1
A Novel Detection Method to Identify Individuals with Alpha-1 Antitrypsin Deficiency: Linking Prescription of COPD Medications with the Patient-Facing Electronic Medical Record1
The Clinical Utility of Determining the Allelic Background of Mutations Causing Alpha-1 Antitrypsin Deficiency: The Case with the Null Variant Q0(Mattawa)/Q0(Ourém)1
Chronic Obstructive Pulmonary Disease and Lung Cancer: A Review for Clinicians1
Waiting for Actionable Evidence: Roflumilast or Azithromycin?1
Decrease in Exacerbations During the Coronavirus Disease 2019 Pandemic in a Cohort of Veterans with COPD1
Association of Patient and Primary Care Provider Factors with Outpatient COPD Care Quality1
Quality of Life and Mortality Outcomes for Augmentation Naïve and Augmented Patients with Severe Alpha-1 Antitrypsin Deficiency1
Computed Tomography Features of Lung Structure Have Utility for Differentiating Malignant and Benign Pulmonary Nodules1
Black Carbon Content in Airway Macrophages is Associated with Reduced CD80 Expression and Increased Exacerbations in Former Smokers With COPD1
Chymotrypsin-like Elastase-1 Mediates Progressive Emphysema in Alpha-1 Antitrypsin Deficiency1
Journal Club-Respiratory Impact of Wildfire Smoke1
Airway and Systemic Prostaglandin E2 Association with COPD Symptoms and Macrophage Phenotype1
Development of the Advancing the Patient Experience in COPD Registry: A Modified Delphi Study1
0.027976989746094